Buscar resultados de ensayos clínicos
Mucopolysaccharidosis II - 50 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: Long-term Evaluation on Height and Weight in Patients With MPS II Who Started Treatment at < 6 Years of Age Condición: Hunter Syndrome Fecha: 2015-05-20 Intervenciones: Drug: Elaprase for intravenous (IV) infusion Patients enrolled in this study will receive once-weekly IV |
Completed |
Nombre del estudio: Collection and Study of Cerebrospinal Fluid in Patients With Hunter Syndrome Condición: Hunter Syndrome Fecha: 2011-10-06 Intervenciones: Other: No treatment |
Completed |
Nombre del estudio: Safety and Clinical Outcomes in Hunter Syndrome Patients 5 Years of Age and Younger Receiving Idursulfase Therapy Condición:
|
Completed |
Nombre del estudio: An Observational Study Evaluating Anti-Idursulfase Serum Antibody Response in Hunter Syndrome Patients Condición: Hunter Syndrome Fecha: 2009-04-16 Intervenciones: Biological: Idursulfase Patients received idursulfase as prescribed by their physician following locally |
Completed |
Nombre del estudio: A Safety and Dose Ranging Study of Idursulfase (Intrathecal) Administration Via an Intrathecal Drug Delivery Device in Pediatric Patients With Hunter Syndrome Who Have Central Nervous System Involvement and Are Receiving Treatment With Elaprase® Condición: Hunter Syndrome Fecha: 2009-06-12 Intervenciones:
|
Enrolling by invitation |
Nombre del estudio: Long-Term Safety and Clinical Outcomes of Idursulfase IT and Elaprase Treatment in Pediatric Patients With Hunter Syndrome That Have Completed Study HGT-HIT-094 Condición: Hunter Syndrome Fecha: 2015-04-01 Intervenciones: Drug: Idursulfase-IT Patients will receive idursulfase-IT treatment once every 28 days at a dose of 10 m |
Completed |
Nombre del estudio: Screening Study to Identify Pediatric Patients With Hunter Syndrome Who Demonstrate Evidence of Central Nervous System (CNS) Involvement and Who Are Currently Receiving Treatment With Elaprase® Condición: Hunter Syndrome Fecha: 2009-07-09 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive Impairment Condición: Hunter Syndrome Fecha: 2014-01-17 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: Extension of HGT-HIT-045 Evaluating Long-Term Safety and Clinical Outcomes of Idursulfase (IT)in Conjunction With Elaprase in Pediatric Patients With Hunter Syndrome and Cognitive Impairment Condición: Hunter Syndrome Fecha: 2011-12-15 Intervenciones: Drug: Idursulfase-IT Idursulfase-IT administered once monthly at the dose used in study HGT-HIT-045 via |
Completed |
Nombre del estudio: Safety and Efficacy of Hunterase Condición: Hunter Syndrome Fecha: 2012-07-16 Intervenciones: Biological: Hunterase once weekly, 0.5mg/kg IV infusion |